Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of ApricityRx™ Digital Therapeutic for Management of Immune-Related Adverse Events in Patients on Immuno-Oncology Therapy

NCT04571398 is registered in ClinicalTrials.gov with Apricity Health, Inc as lead sponsor.

NCT NCT04571398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04571398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of ApricityRx™ Digital Therapeutic for Management of Immune-Related Adverse Events in Patients on Immuno-Oncology Therapy
Lead sponsor
Apricity Health, Inc
Phase
Observational
Overall status
Unknown status
Start date
November 19, 2019
Completion date
October 15, 2023
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer